23 May 2013
Keywords: herceptin, gets, fda, ok, her2, node, usa-based
Article | 27 November 2006
USA-based biotechnology major Genentech says that its anticancer agent Herceptin (trastuzumab) has been approved by the Food and Drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 November 2006
4 December 2006
18 December 2006
© 2013 thepharmaletter.com